Application no. and date | 02793761.4 (espacenet) (Federated) (European Patent Register), 20020723 | Patent/reg. no. and date | DK/EP 1417231, 20130619 | Publication date | 20040512 | Priority no. and date | US 307345 P, 20010723 | EP pub. no. and date |
EP 1417231 20040512 | Effective date | | Applicant/owner | Immunex Corporation, One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | Applicant ref. no. | 01716-EP-DK | Inventor | VAN NESS, Kirk, P., 6726 42nd Avenue S.W.
Seattle, WA 98136, US, PAXTON, Raymond, J., 6583 156th Avenue SE
Bellevue, WA 98006, US, LYMAN, Stewart, D., 1836 North 53rd Street
Seattle, WA 98103, US | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 38/20 (2006.01) , A61K 48/00 (2006.01) , C07K 14/54 (2006.01) , C07K 16/24 (2006.01) , C12N 15/24 (2006.01) , C12N 15/63 (2006.01) , C12N 5/10 (2006.01) | Title | MODIFICERET HUMAN THYMISK STROMAL LYMPHOPOIETIN | Int. application no. | US2002023475 | Int. publication no. | WO2003032898 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|